| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22 |
| filingDate |
2015-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2752710b88845f841d800e2e18de2144
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0ec7403600bcee5e4d5f91a6b977933
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94688b5b3034f74a50d982b8781fb061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_728a910c75596d0acf25d558d0ce12a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce6eeb88448a415d62e4b2e03c509f0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc08cc2fa36f7eca484cd16b83b4bccf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cf01c742a5dd03b22cabbee6035d511 |
| publicationDate |
2017-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20170082594-A |
| titleOfInvention |
Anti-ang2 antibodies and methods of use |
| abstract |
The present invention is directed to the reported anti-ANG2 antibodies. A particular anti-ANG2 antibody comprises (a) HVR-H1 comprising the amino acid sequence of SEQ ID NO: 29; (b) HVR-H2 comprising the amino acid sequence of SEQ ID NO: 30; And (c) HVR-H3 comprising the amino acid sequence of SEQ ID NO: 32. |
| priorityDate |
2014-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |